Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters.

Numerous diseases, recently reported to associate with elevated microvesicle/microparticle (MP) counts, have also long been known to be characterized by accelerated immune complex (IC) formation. The goal of this study was to investigate the potential overlap between parameters of protein complexes (eg, ICs or avidin-biotin complexes) and MPs, which might perturb detection and/or isolation of MPs. In this work, after comprehensive characterization of MPs by electron microscopy, atomic force microscopy, dynamic light-scattering analysis, and flow cytometry, for the first time, we drive attention to the fact that protein complexes, especially insoluble ICs, overlap in biophysical properties (size, light scattering, and sedimentation) with MPs. This, in turn, affects MP quantification by flow cytometry and purification by differential centrifugation, especially in diseases in which IC formation is common, including not only autoimmune diseases, but also hematologic disorders, infections, and cancer. These data may necessitate reevaluation of certain published data on patient-derived MPs and contribute to correct the clinical laboratory assessment of the presence and biologic functions of MPs in health and disease.

[1]  R. Cardigan,et al.  Microparticle sizing by dynamic light scattering in fresh‐frozen plasma , 2009, Vox sanguinis.

[2]  D. Mukhopadhyay,et al.  Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression. , 2010, Blood.

[3]  L. Arnaud,et al.  Standardization of platelet‐derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? , 2009, Journal of thrombosis and haemostasis : JTH.

[4]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[5]  L. Horstman,et al.  High levels of circulating endothelial microparticles in patients with acute coronary syndromes. , 2003, American heart journal.

[6]  N. Khlebtsov,et al.  A method for studying insoluble immune complexes. , 2004, Biochimica et biophysica acta.

[7]  D. Theodorescu,et al.  Isolation and identification of potential urinary microparticle biomarkers of bladder cancer. , 2008, Journal of proteome research.

[8]  J. Klein,et al.  Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome. , 2010, Kidney international.

[9]  L. Berglund,et al.  Circulating Immune Complexes in 50-Year-Old Men as a Strong and Independent Risk Factor for Myocardial Infarction , 2000, Circulation.

[10]  T. Möller,et al.  Astrocyte-Derived ATP Induces Vesicle Shedding and IL-1β Release from Microglia1 , 2005, The Journal of Immunology.

[11]  Richard W. Farndale,et al.  Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production , 2010, Science.

[12]  K. Davies Michael Mason Prize Essay 1995. Complement, immune complexes and systemic lupus erythematosus. , 1996, British journal of rheumatology.

[13]  I. Takei,et al.  Simplified method for the diameter sizing of serum low-density lipoprotein using polyacrylamide gradient gel electrophoresis , 2004, Clinical chemistry and laboratory medicine.

[14]  Aled Clayton,et al.  Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids , 2006, Current protocols in cell biology.

[15]  J. Altin,et al.  The formation of insoluble immune complexes between ovalbumin and anti-ovalbumin IgG occurs in at least two distinct phases dependent on reactant concentration and ionic strength. , 1996, Biochimica et biophysica acta.

[16]  Fred Jacobson,et al.  Protein aggregation and bioprocessing , 2006, The AAPS Journal.

[17]  Marianne,et al.  Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals , 2008 .

[18]  I. Okpala,et al.  Complement haemolytic activity, circulating immune complexes and the morbidity of sickle cell anaemia , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[19]  O. Iversen,et al.  Preparative Isolation of Immune Complexes from Serum by Sucrose Gradient Ultracentrifugation , 1984, Scandinavian journal of immunology.

[20]  P. Hinterdorfer,et al.  Ca(++)-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin. , 2002, Blood.

[21]  Scott D. Cohen,et al.  Immune complex renal disease and human immunodeficiency virus infection. , 2008, Seminars in nephrology.

[22]  J. Heinecke,et al.  The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses. , 2008, Biochemistry.

[23]  T. Schneider-Axmann,et al.  Circulating immune complexes of Aβ and IgM in plasma of patients with Alzheimer’s disease , 2009, Journal of Neural Transmission.

[24]  D. Lewis,et al.  Flow cytometric analysis of circulating microparticles in plasma , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[25]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[26]  L. Norton,et al.  A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with prosorba columns for treating metastatic breast cancer , 1995, Cancer.

[27]  R. Nieuwland,et al.  Measuring circulating cell‐derived microparticles , 2004, Journal of thrombosis and haemostasis : JTH.

[28]  W. Ax,et al.  Incidence of circulating immune complexes in patients with lung cancer and their effect on antibody-dependent cytotoxicity. , 1980, Oncology.

[29]  B. Gibson,et al.  Biochemical and Functional Characterization of Membrane Blebs Purified from Neisseria meningitidis Serogroup B* , 2005, Journal of Biological Chemistry.

[30]  T. Möller,et al.  Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. , 2005, Journal of immunology.

[31]  P. Kovács,et al.  T lymphocytes are targets for platelet- and trophoblast-derived microvesicles during pregnancy. , 2008, Placenta.

[32]  I. Bauerfeind,et al.  Platelet-derived microparticles and coagulation activation in breast cancer patients , 2008, Thrombosis and Haemostasis.

[33]  J. Freyssinet,et al.  Centrifugation is a crucial step impacting microparticle measurement , 2009, Platelets.

[34]  Esther Lutgens,et al.  CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization. , 2008, Journal of the American College of Cardiology.

[35]  J. W. Gallagher,et al.  Overexpression of Apolipoprotein A-IV Enhances Lipid Secretion in IPEC-1 Cells by Increasing Chylomicron Size* , 2006, Journal of Biological Chemistry.

[36]  D. Pisetsky,et al.  The role of microparticles in the pathogenesis of rheumatic diseases , 2010, Nature Reviews Rheumatology.

[37]  G. Silverman,et al.  Roles of B cells in rheumatoid arthritis , 2003, Arthritis research & therapy.

[38]  X. Mariette,et al.  Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity , 2009, Arthritis research & therapy.

[39]  A. Casadevall,et al.  Extracellular Vesicles from Cryptococcus neoformans Modulate Macrophage Functions , 2010, Infection and Immunity.

[40]  M. Kapsokefalou,et al.  Effect of milk peptides that enhance iron uptake by Caco‐2 cells on the expression of DMT‐1 and on iron dialyzability from meals , 2008 .

[41]  D. Pisetsky,et al.  Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. , 2005, Arthritis and rheumatism.

[42]  Linda O. Narhi,et al.  Effect of Ions on Agitation- and Temperature-Induced Aggregation Reactions of Antibodies , 2009, Pharmaceutical Research.

[43]  J. Gottenberg,et al.  Microparticle-induced release of B-lymphocyte regulators by rheumatoid synoviocytes , 2009, Arthritis research & therapy.

[44]  S. Stanilova,et al.  Comparative study of circulating immune complexes quantity detection by three assays--CIF-ELISA, C1q-ELISA and anti-C3 ELISA. , 2001, JIM - Journal of Immunological Methods.

[45]  P. Pontisso,et al.  Squamous cell carcinoma antigen‐immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma , 2005, Cancer.

[46]  S. Jancar,et al.  Immune complex-mediated tissue injury: a multistep paradigm. , 2005, Trends in immunology.

[47]  P. Roughley,et al.  Age-related changes in protein-related epitopes of human articular-cartilage proteoglycans. , 1986, The Biochemical journal.

[48]  G. Escolar,et al.  Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. , 2004, Blood.

[49]  R. Haugland,et al.  Coupling of monoclonal antibodies with biotin. , 1995, Methods in molecular biology.